- Home
- ICMB vs SRZN Comparison
ICMB vs SRZN Comparison
Compare ICMB & SRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ICMB
- SRZN
- Stock Information
- Founded
- ICMB 2012
- SRZN 2015
- Country
- ICMB United States
- SRZN United States
- Employees
- ICMB N/A
- SRZN N/A
- Industry
- ICMB Finance: Consumer Services
- SRZN Medicinal Chemicals and Botanical Products
- Sector
- ICMB Finance
- SRZN Health Care
- Exchange
- ICMB Nasdaq
- SRZN Nasdaq
- Market Cap
- ICMB 44.2M
- SRZN 38.1M
- IPO Year
- ICMB N/A
- SRZN N/A
- Fundamental
- Price
- ICMB $3.08
- SRZN $12.08
- Analyst Decision
- ICMB
- SRZN Strong Buy
- Analyst Count
- ICMB 0
- SRZN 1
- Target Price
- ICMB N/A
- SRZN $45.00
- AVG Volume (30 Days)
- ICMB 36.8K
- SRZN 53.7K
- Earning Date
- ICMB 02-10-2025
- SRZN 11-06-2024
- Dividend Yield
- ICMB 15.58%
- SRZN N/A
- EPS Growth
- ICMB N/A
- SRZN N/A
- EPS
- ICMB 0.29
- SRZN N/A
- Revenue
- ICMB $24,827,371.00
- SRZN $10,000,000.00
- Revenue This Year
- ICMB N/A
- SRZN N/A
- Revenue Next Year
- ICMB N/A
- SRZN N/A
- P/E Ratio
- ICMB $10.56
- SRZN N/A
- Revenue Growth
- ICMB N/A
- SRZN N/A
- 52 Week Low
- ICMB $2.91
- SRZN $6.00
- 52 Week High
- ICMB $3.77
- SRZN $18.17
- Technical
- Relative Strength Index (RSI)
- ICMB 48.90
- SRZN 50.51
- Support Level
- ICMB $3.00
- SRZN $10.20
- Resistance Level
- ICMB $3.08
- SRZN $12.51
- Average True Range (ATR)
- ICMB 0.06
- SRZN 2.03
- MACD
- ICMB 0.00
- SRZN -0.29
- Stochastic Oscillator
- ICMB 80.00
- SRZN 24.91
About ICMB Investcorp Credit Management BDC Inc.
Investcorp Credit Management BDC Inc is an externally managed, non-diversified closed-end management investment firm that has elected to be regulated as a business development company (BDC). Its investment objective is to maximize total return to stockholders in the form of current income and capital appreciation by investing in debt and related equity of privately held lower middle-market companies. The company principally invests in the debt of middle-market companies, which it defines as those companies that have an enterprise value.
About SRZN Surrozen Inc.
Surrozen Inc is a clinical-stage biotechnology company committed to discovering and developing drug candidates to selectively modulate the Wnt pathway, a critical mediator of tissue repair, in a broad range of organs and tissues. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), SZN-413 and SZN-043 (E3/ASGR1, SWEETS).